The Epidemic of Human Papillomavirus and Oropharyngeal Cancer in a Canadian Population
Authors:
Open Access
- 1 August 2013
- journal article
- Published by MDPI AG in Current Oncology
- Vol. 20 (4) , 212-219
Abstract
Background: Sexually transmitted infection with the human papillomavirus (HPV) is responsible for a significant burden of human cancers involving the cervix, anogenital tract, and oropharynx. Studies in the United States and Europe have demonstrated an alarming increase in the frequency of HPV-positive oropharyngeal cancer, but the same direct evidence does not exist in Canada. Methods: Using the London Health Sciences Centre pathology database, we identified tonsillar cancers diagnosed between 1993 and 2011. Real-time polymerase chain reaction was then used on pre-treatment primary-site biopsy samples to test for DNA from the high-risk HPV types 16 and 18. The study cohort was divided into three time periods: 1993–1999, 2000–2005, and 2006–2011. Results: Of 160 tumour samples identified, 91 (57%) were positive for HPV 16. The total number of tonsillar cancers significantly increased from 1993–1999 to 2006–2011 (32 vs. 68), and the proportion of cases that were HPV-positive substantially increased (25% vs. 62%, p < 0.002). Those changes were associated with a marked improvement in 5-year overall survival (39% in 1993–1999 vs. 84% in 2006–2011, p < 0.001). When all factors were included in a multivariable model, only HPV status predicted treatment outcome. Interpretation: The present study is the first to provide direct evidence that HPV-related oropharyngeal cancer is increasing in incidence in a Canadian population. Given the long lag time between HPV infection and clinically apparent malignancy, oropharyngeal cancer will be a significant clinical problem for the foreseeable future despite vaccination efforts.Keywords
This publication has 16 references indexed in Scilit:
- Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) – study protocol for a randomized phase II trialBMC Cancer, 2013
- Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant MetastasisJournal of Clinical Oncology, 2013
- Does HPV type affect outcome in oropharyngeal cancer?Journal of Otolaryngology - Head & Neck Surgery, 2013
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)‐related and HPV‐unrelated sites in a multicultural populationCancer, 2010
- Twenty-Year Trends in the Incidence and Prevalence of Diagnosed Anogenital Warts in CanadaSexually Transmitted Diseases, 2009
- Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma?International Journal of Cancer, 2009
- Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG AnalysisJournal of Clinical Oncology, 2008
- Human Papillomavirus Type 18: Association With Poor Prognosis in Early Stage Cervical CancerJNCI: Journal of the National Cancer Institute, 1996